CEF30, Epstein-Barr Virus BRLF1 (134-142)

CEF30 is a BRLF1-derived peptide used to investigate EBV regulatory-protein motifs. Its sequence supports studies of loop alignment and solvent exposure. Researchers examine conformational properties to identify structural determinants. The molecule aids viral regulatory-peptide analyses.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: C14029

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide Analysis ServicesPeptide Modification ServicesPeptide Synthesis ServicesEpitope Mapping ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers